Modal close

Dear Democracy Now! visitor,

You turn to Democracy Now! for ad-free news you can trust. Maybe you come for our daily headlines. Maybe you come for in-depth stories that expose corporate and government abuses of power. Democracy Now! brings you crucial reporting like our coverage from the front lines of the standoff at Standing Rock or news about the movements fighting for peace, racial and economic justice, immigrant rights and LGBTQ equality. We produce our daily news hour at a fraction of the budget of a commercial news operation—all without ads, government funding or corporate sponsorship. How is this possible? Only with your support. If every visitor to this site in December gave just $10 we could cover our basic operating costs for 2017. Pretty exciting, right? So, if you've been waiting to make your contribution to Democracy Now!, today is your day. It takes just a couple of minutes to make sure that Democracy Now! is there for you and everybody else in 2017.

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Topics

The Other Drug War: Pharmaceutical Companies and WTO Sue Brazil and South Africa to Protectprices and Patents

StoryFebruary 15, 2001
Watch iconWatch Full Show

The world’s giant pharmaceutical companies hold the patents to medicines that would save or prolong of lives ofmillions of people in the developing world if those people there could afford them. In the last few years, developingnations have implemented two strategies to get drugs to those who need them and break the drug companies’ monopoly.Countries can either manufacture their own cheap drugs to override patents, which is what Brazil is doing, or, likeSouth Africa, they can import a drug from wherever it was sold cheapest.

The drug industry has responded with its own two-pronged strategy. At the instigation of the US, the World TradeOrganization is challenging Brazil’s right to manufacture its own inexpensive drugs. Since Brazil started producingnon-patented Aids drugs, the death rate in that country from AIDS has been halved.

The second prong of the pharmaceutical companies’ strategy is aimed at South Africa. Some 42 pharmaceutical companies,including the British giant GlaxoSmithKline are suing the African nation which has 25 million people infected withHIV/AIDS. They have launched a lawsuit to prevent South Africa from importing inexpensive drugs manufactured in suchcountries as India.

Now Oxfam which usually confine their work to humanitarian intervention, is taking aim in the other drug war andlaunching a campaign against Glaxo.

Guests:

  • Kevin Watkins, senior policy advisor at Oxfam UK.
  • Larry Elliott, economics editor of the Guardian [London].
  • Ambassador Celso Amorim, head of the Brazilian trade mission in Geneva and Brazilian ambassador tointernational organizations including the WTO.
  • Dr. Anne-Valerie Kaninda, medical advisor to Doctors Without Borders.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.

Make a donation